Caricamento...
Biological Drugs in Guillain-Barré Syndrome: An Update
BACKGROUND: Guillain-Barré Syndrome (GBS) is currently considered the most common global cause of acute flaccid paralysis. Currently, standard therapy for Guillain-Barré Syndrome includes intravenous immunoglobulin or plasma exchange. Despite medical advances regarding these treatments, many treated...
Salvato in:
| Pubblicato in: | Curr Neuropharmacol |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Bentham Science Publishers
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5652014/ https://ncbi.nlm.nih.gov/pubmed/27964705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X14666161213114904 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|